NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Free peptide testing

Ordered peptides from Noble Dragons? Mail in a sample (US only) and let us test it.

Test my supply
+2 more ↓
73%
Finnrick rating
#236 of 457 ranked vendors
16 of 23 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Noble Dragons' purity-focused record is strongest on Tirzepatide, where identity, purity, and fill evidence is consistently clean despite batch-info gaps. Retatrutide is much more dispersed, shifting from an early clean run to volatile and recent hard purity/fill failures, leaving a current but split catalog signal.

methodology →
vendor intelligence report
Vendor Intelligence Report: Noble Dragons

We investigated who actually operates Noble Dragons — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

19 pages5 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Tirzepatide
$0.63
86%
9
2
Retatrutide
$1.79
61%
14
3
BPC-157
$1.29
-
0
4
Cagrilintide
$2.99
-
0
5
GHK-Cu
$0.14
-
0
6
KPV
$1.29
-
0
7
PT-141
$1.29
-
0
8
Semaglutide
$1.00
-
0
9
TB-500
$2.00
-
0
10
Tesamorelin
$2.89
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%11 Dec 2025: 79%26 Jan 2026: 78%29 Jan 2026: 79%29 Jan 2026: 79%10 Feb 2026: 80%15 Feb 2026: 81%20 Feb 2026: 81%20 Feb 2026: 82%22 Feb 2026: 82%26 Feb 2026: 81%26 Feb 2026: 81%2 Mar 2026: 82%3 Mar 2026: 80%10 Mar 2026: 81%16 Mar 2026: 81%18 Mar 2026: 79%28 Apr 2026: 80%1 Jun 2026: 81%12 Jun 2026: 79%12 Jun 2026: 77%5 Aug 2026: 77%7 Sep 2026: 76%24 Sep 2026: 74%7 Oct 2026: current 73%79%80%73%Dec 25Oct 26
Free peptide testing

Ordered peptides from Noble Dragons? Mail in a sample (US only) and let us test it.

Test my supply
Noble Dragons test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
24 Sep 2026
Fail
Retatrutide
lab nameView COA
7 Sep 2026
Fail
Retatrutide
lab nameView COA
5 Aug 2026
Pass
Tirzepatide
lab nameView COA
12 Jun 2026
Fail
Retatrutide
lab nameView COA
12 Jun 2026
Fail
Retatrutide
lab nameView COA
1 Jun 2026
Pass
Retatrutide
lab nameView COA
28 Apr 2026
Pass
Tirzepatide
lab nameView COA
18 Mar 2026
Fail
Retatrutide
lab nameView COA
16 Mar 2026
Pass
Retatrutide
lab nameView COA
10 Mar 2026
Pass
Retatrutide
lab nameView COA
1-10 of 23

About Noble Dragons test results from Finnrick

Noble Dragons is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 2 peptides and 23 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Noble Dragons peptides in this dataset are Retatrutide (14 tests), Tirzepatide (9 tests) and BPC-157 (0 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 23 recent tests.

Corrections
No corrections.
Free peptide testing

Ordered peptides from Noble Dragons? Mail in a sample (US only) and let us test it.

Test my supply